GSK-812

CAS No. 630407-66-8

GSK-812 ( GSK812 )

Catalog No. M15383 CAS No. 630407-66-8

GSK-812 is a potent neuroprotectant that can induce GDNF in normal and diseased retina.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-812
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-812 is a potent neuroprotectant that can induce GDNF in normal and diseased retina.
  • Description
    GSK-812 is a potent neuroprotectant that can induce GDNF in normal and diseased retina, shows has polypharmacology antagonizing multiple receptors, including D2 and D3 receptors, and 5-HT2A, 2C, and 5-HT6 receptors.
  • Synonyms
    GSK812
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    630407-66-8
  • Formula Weight
    472.00
  • Molecular Formula
    C25H26ClNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1CCC2=CC(=C(C=C2CC1)S(=O)(=O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)Cl)OC
  • Chemical Name
    7-[4-(4-chloro-benzyloxy)-benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Baranov P, et al. J Ocul Pharmacol Ther. 2017 Jun;33(5):412-422.
molnova catalog
related products
  • Ondansetron hydrochl...

    Ondansetron is a serotonin 5-HT receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.

  • TETRABENAZINE(b)

    Tetrabenazine (Racemate) is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).

  • Elbasvir

    Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.